Found: 28
Select item for more details and to access through your institution.
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Identification of mouse helper epitopes for WT1-specific CD4<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3323, doi. 10.1007/s00262-021-03003-5
- By:
- Publication type:
- Article
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3249, doi. 10.1007/s00262-021-02934-3
- By:
- Publication type:
- Article
CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3235, doi. 10.1007/s00262-021-02931-6
- By:
- Publication type:
- Article
Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3069, doi. 10.1007/s00262-021-02996-3
- By:
- Publication type:
- Article
TARP as antigen in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3061, doi. 10.1007/s00262-021-02972-x
- By:
- Publication type:
- Article
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3349, doi. 10.1007/s00262-021-02965-w
- By:
- Publication type:
- Article
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3337, doi. 10.1007/s00262-021-02986-5
- By:
- Publication type:
- Article
Immune checkpoint inhibitors-induced nephropathy: a French national survey.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3357, doi. 10.1007/s00262-021-02983-8
- By:
- Publication type:
- Article
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3199, doi. 10.1007/s00262-021-02926-3
- By:
- Publication type:
- Article
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3313, doi. 10.1007/s00262-021-02925-4
- By:
- Publication type:
- Article
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3277, doi. 10.1007/s00262-021-02924-5
- By:
- Publication type:
- Article
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3303, doi. 10.1007/s00262-021-02920-9
- By:
- Publication type:
- Article
Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3291, doi. 10.1007/s00262-021-02919-2
- By:
- Publication type:
- Article
Distinct genomic features across cytolytic subgroups in skin melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3137, doi. 10.1007/s00262-021-02918-3
- By:
- Publication type:
- Article
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3155, doi. 10.1007/s00262-021-02915-6
- By:
- Publication type:
- Article
Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3093, doi. 10.1007/s00262-021-02914-7
- By:
- Publication type:
- Article
RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3261, doi. 10.1007/s00262-021-02913-8
- By:
- Publication type:
- Article
Cancer therapy in mice using a pure population of CD8<sup>+</sup> T cell specific to the AH1 tumor rejection antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3183, doi. 10.1007/s00262-021-02912-9
- By:
- Publication type:
- Article
Enhancement of innate and adaptive anti-tumor immunity by serum obtained from vascular photodynamic therapy-cured BALB/c mouse.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3217, doi. 10.1007/s00262-021-02917-4
- By:
- Publication type:
- Article
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3207, doi. 10.1007/s00262-021-02911-w
- By:
- Publication type:
- Article
Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3105, doi. 10.1007/s00262-021-02905-8
- By:
- Publication type:
- Article
Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3167, doi. 10.1007/s00262-021-02899-3
- By:
- Publication type:
- Article
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3081, doi. 10.1007/s00262-021-02892-w
- By:
- Publication type:
- Article
Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3113, doi. 10.1007/s00262-021-02906-7
- By:
- Publication type:
- Article
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3123, doi. 10.1007/s00262-021-02871-1
- By:
- Publication type:
- Article